Publications by authors named "Athanasios D Anastasilakis"

Claim this Profile
D
Diagnosis and management of primary hyperparathyroidism: recommendations from the Bone Section of the Hellenic Endocrine Society.
Athanasios D Anastasilakis, Maria P Yavropoulou, Evanthia Kassi, Fotini Adamidou, Andromachi Vryonidou

Hormones (Athens)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and management of hypoparathyroidism: recommendations of the working group of the Bone Section of the Hellenic Endocrine Society.
Evanthia Kassi, Fotini Adamidou, Maria P Yavropoulou, Athanasios D Anastasilakis, Polyzois Makras

Hormones (Athens)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Diagnosis and management of hypoparathyroidism: recommendations of the working group of the bone section of the Hellenic endocrine society.
Evanthia Kassi, Fotini Adamidou, Maria P Yavropoulou, Athanasios D Anastasilakis, Polyzois Makras

Hormones (Athens)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EndoCompass Project: Research Roadmap for Calcium and Bone Endocrinology.
Katharina Jähn-Rickert, Karin Zibar Tomšić, Athanasios D Anastasilakis, Jean-Philippe Bertocchio, Maria Luisa Brandi

Horm Res Paediatr· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of fractures in patients with solid cancers treated with immune checkpoint inhibitors: a systematic review and meta-analysis of randomised controlled trials.
Maria P Yavropoulou, Dimitrios A Anastasilakis, Maria-Iosifina Kasdagli, Chrysoula G Gialouri, Konstantinos Palaiopanos, Athanasios D Anastasilakis

BMJ Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treating osteoporosis with denosumab or bisphosphonates in the long term: facts, uncertainties and assumptions. A narrative review by the clinical action group of the European Calcified Tissue Society (ECTS).
Anda Mihaela Naciu, Gaia Tabacco, Andrea Palermo, Maria P Yavropoulou, Tim Rolvien, Athanasios D Anastasilakis

Bone· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PTH-driven modulation of platelet activity via the NOX2 pathway in postsurgical hypoparathyroidism.
Alessandra D'Amico, Gaia Tabacco, Cristina Nocella, Anda Mihaela Naciu, Annunziata Nusca, Athanasios D Anastasilakis

Redox Biol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Effects of Obesity and Weight Loss Interventions on Bone Health: A Narrative Review.
Andrea Palermo, Elena Tsourdi, Maria P Yavropoulou, Anda Mihaela Naciu, Gaia Tabacco, Athanasios D Anastasilakis

Curr Diab Rep· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
EndoCompass project: research roadmap for calcium and bone endocrinology.
Katharina Jähn-Rickert, Karin Zibar Tomšić, Athanasios D Anastasilakis, Jean-Philippe Bertocchio, Maria Luisa Brandi

Eur J Endocrinol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of anti-obesity medications on bone metabolism: A critical appraisal.
Athanasios D Anastasilakis, Julien Paccou, Andrea Palermo, Stergios A Polyzos

Diabetes Obes Metab· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
No overshoot of bone turnover after withdrawal of denosumab treatment of adults with Langerhans cell histiocytosis: a prospective clinical trial.
Polyzois Makras, Maria P Yavropoulou, Athanasios D Anastasilakis, Athanasios Papatheodorou, Socrates E Papapoulos

Osteoporos Int· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiresorptive Therapy to Reduce Fracture Risk and Effects on Dental Implant Outcomes in Patients With Osteoporosis: A Systematic Review and Osteonecrosis of the Jaw Taskforce Consensus Statement.
Dalal S Ali, Aliya A Khan, Archibald Morrison, Sotirios Tetradis, Reza D Mirza, Athanasios D Anastasilakis

Endocr Pract· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Follistatins, activins and inhibins during osteoporosis therapy with denosumab or zoledronate and after their discontinuation.
Athanasios D Anastasilakis, Polyzois Makras, Stergios A Polyzos, Ajay Kumar, Bhanu Kalra

Diabetes Obes Metab· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Î
Τhe story of sclerostin inhibition: the past, the present, and the future.
Athanasios D Anastasilakis, Elena Tsourdi

Hormones (Athens)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current and emerging bone resorption inhibitors for the treatment of osteoporosis.
Apostolos I Gogakos, Athanasios D Anastasilakis

Expert Opin Pharmacother· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Basic and Clinical Scientists Working Together-Do We Make the Best of Both Worlds?
Willem F Lems, Athanasios D Anastasilakis, Christina Møller Andreasen, Julien Paccou, Tim Rolvien

Calcif Tissue Int· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteokines in Nonalcoholic Fatty Liver Disease.
Ilias D Vachliotis, Athanasios D Anastasilakis, Vasileios Rafailidis, Stergios A Polyzos

Curr Obes Rep· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention and treatment of glucocorticoid-induced osteoporosis in adults: recommendations from the European Calcified Tissue Society.
Julien Paccou, Maria P Yavropoulou, Anda Mihaela Naciu, Manju Chandran, Osvaldo D Messina, Athanasios D Anastasilakis

Eur J Endocrinol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary hyperparathyroidism: from guidelines to outpatient clinic.
Andrea Palermo, Gaia Tabacco, Polyzois Makras, Guido Zavatta, Pierpaolo Trimboli, Athanasios D Anastasilakis

Rev Endocr Metab Disord· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The comparative effect of teriparatide and denosumab on activins, follistatins, and inhibins in women with postmenopausal osteoporosis.
Athanasios D Anastasilakis, Stergios A Polyzos, Polyzois Makras, Matthaios Savvidis, Christos S Mantzoros

J Bone Miner Res· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Conservative Treatments in the Management of Acute Painful Vertebral Compression Fractures: A Systematic Review and Network Meta-Analysis.
Assil-Ramin Alimy, Athanasios D Anastasilakis, John J Carey, Stella D'Oronzo, Anda M Naciu

JAMA Netw Open· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Romosozumab versus parathyroid hormone receptor agonists: which osteoanabolic to choose and when?
Athanasios D Anastasilakis, Maria P Yavropoulou, Andrea Palermo, Polyzois Makras, Julien Paccou

Eur J Endocrinol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment.
Polyzois Makras, Maria P Yavropoulou, Athanasios D Anastasilakis, Athanasios Papatheodorou, Christos Tekedis

Osteoporos Int· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between length of denosumab treatment for postmenopausal osteoporosis and serum TRAcP5b measured six months after the last injection.
Polyzois Makras, Maria P Yavropoulou, Stergios A Polyzos, Socrates E Papapoulos, Danai Georgakopoulou, Athanasios D Anastasilakis

Osteoporos Int· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nocebo-associated treatment discontinuation with subcutaneous anti-osteoporotic drugs. A systematic review and meta-analysis of placebo-arm dropouts in randomized-controlled trials.
Maria P Yavropoulou, Maria-Iosifina Kasdagli, Polyzois Makras, Konstantina-Maria Diomatari, Athanasios D Anastasilakis

Maturitas· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis